TRENDING :  Market Movers  |  Top 50   AAPL (-0.23%)    FB (-0.89%)    KO (-0.77%)    AMZN (-0.91%)    UGAZ (4.96%)    VXXB (-3.5%)    MGM (3.07%)    MDB (1.02%)    KRE (2.17%)    AMD (2.38%)    ABMD (1.19%)    AA (0.25%)    IVC (12.08%)    HTGM (2.18%)    GOOS (-2.76%)    GH (4.51%)    GEVO (1.66%)    FUV (-31.27%)    FCEL (12.84%)    DIS (1.75%)    DGAZ (-4.98%)    CRON (2.26%)    CRM (-0.27%)    CGC (3.13%)    CAT (2.7%)

 CBM - Cambrex Corporation

$37.68 [1.89][5.26%]

Next Earnings



Trade Idea »


No recommendations found.

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.


Service NameTrader% Success
Swingers CornerAkemi Mokoto43.00 %Follow


3 Top Biotech Stocks to Buy in February

12:00 AM
Biotech stocks ended 2018 with a thud However the industry has clearly regained its footing early on in 2019 evinced by the iShares Nasdaq Biotechnology Index s 16 surge higher during just the first six weeks of the new year So with the biotech space solidly on the

Cambrex Corp (CBM) Q4 2018 Earnings Conference Call Transcript

Image source The Motley Fool Cambrex Corp NYSE CBM Q4 160 2018 Earnings Conference Call Feb 13 2019 8 30 a m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator Ladies

Why Cambrex Corporation Is Tanking Today

What happened In response to reporting of fourth quarter and full year quarterly results shares of Cambrex Corporation NYSE CBM a supplier to the life sciences industry fell 11 as of 11 10 a m EST on Wednesday So what Here are the headline numbers from the

Cambrex (CBM) Surpasses Q4 Earnings Estimates

Cambrex CBM came out with quarterly earnings of 1 44 per share beating the Zacks Consensus Estimate of 1 40 per share This compares to earnings of 1 27 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise of 2 86

Cambrex (CBM) Upgraded to Buy: Here's What You Should Know

Cambrex CBM could be a solid choice for investors given its recent upgrade to a Zacks Rank 2 Buy This upgrade primarily reflects an upward trend in earnings estimates which is one of the most powerful forces impacting stock prices The Zacks rating relies solely on a company s

Validea's Top Five Energy Stocks Based On Joseph Piotroski - 2/10/2019

The following are the top rated Energy stocks according to Validea s Book Market Investor model based on the published strategy of Joseph Piotroski This value quant strategy screens for high book to market stocks and then separates out financially sound firms by looking at a host of

CBM or ILMN: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical Biomedical and Genetics stocks have likely encountered both Cambrex CBM and Illumina ILMN But which of these two companies is the best option for those looking for undervalued stocks Let s take a closer look We have found that the best way to

Noteworthy Wednesday Option Activity: CBM, V, PYPL

Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Cambrex Corp Symbol CBM where a total volume of 1 792 contracts has been traded thus far today a contract volume which is representative of approximately 179 200